Academic alliances to speed Lilly’s R&D
March 1, 2012Research and Development, Sales and Marketing R&D, academia, break through drugs, collaboration, lilly
Lilly has unveiled a range of collaborations with academic researchers which it says will help it discover and develop more …
AstraZeneca announces several non-executive moves
March 1, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, appointments
AstraZeneca has announced that Leif Johansson is set to be elected as a non-executive director in April, with the intention …
Novartis appoints Brian McNamara to division head of OTC business
March 1, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Brian McNamara, Novartis, OTC
Novartis has appointed Brian McNamara to the position of division head of its OTC (Over-the-Counter) business with immediate effect. McNamara …
‘Rare Disease Day’ highlights need for research
February 29, 2012Research and Development, Sales and Marketing Genzyme, Rare Disease Day, Shire
Today has been designated as Rare Disease Day around the world, with researchers, regulators and the industry all raising awareness …
A wake-up call for big pharma
February 29, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, McKinsey, business models, pharma
The good old days of the pharmaceutical industry are gone forever. Even an improved global economic climate is unlikely to …
Abbott buys into Galapagos’ RA candidate
February 29, 2012Research and Development, Sales and Marketing Abbott, Galapagos, Humira, JAK, RA, TNF
Abbott has struck a deal with Galapagos to develop and commercialise a promising oral JAK1 inhibitor to treat multiple autoimmune …
Shire signs antibody research deal with arGEN-X
February 29, 2012Research and Development Shire, arGEN-X, monoclonal antibodies
Shire has signed a deal with antibody specialists arGEN-X to develop drugs for rare genetic diseases.Rotterdam-based arGEN-X will use its …
LEO Pharma appoints new executive vice president
February 29, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing LEO Pharma, supply chain
From March Anders Spohr will take over the position of executive vice president for global product supply at LEO Pharma. …
NHS must adopt new technologies faster, says minister
February 28, 2012Research and Development ABPI, NHS, Whitehead, Willetts, innovation
The NHS needs to speed up its adoption of new technology, according to universities and science minister David Willetts. Echoing …
ICON acquires market access consultancy
February 28, 2012Research and Development CRO, ICON, pharma market access, pricing and reimbursement
ICON has acquired consulting firm PriceSpective, helping to expand the contract research organisation’s services in the field of pricing and …
Doctors don’t want rationing responsibility, finds survey
February 28, 2012Sales and Marketing Commissioning Board, NHS, NHS reforms, NHSCB, NICE, rationing
A survey of GPs in England has found that most do not want powers to ration care for NHS patients.The …
Jon Linscott to head PAN Advertising
February 28, 2012Business Services, Medical Communications, Sales and Marketing Creston Health, Jon Linscott, Pan Advertising
Jon Linscott has been appointed managing director of PAN Advertising, a member of the Creston Health group of companies. Linscott …
GSK recalls Novartis’ blood pressure drug
February 28, 2012Manufacturing and Production DynaCirc CR, GSK, Novartis
GlaxoSmithKline is the latest company to be affected by manufacturing glitches at Novartis’ troubled facility in Lincoln, Nebraska, having been …
EMA confirms verdict on Ben Venue facility
February 28, 2012Manufacturing and Production Ben Venue, CHMP, EMA, Sanofi
The European Medicines Agency has officially removed Ben Venue Laboratories’ troubled Bedford facility as an approved location for the manufacture …
Shire’s Vpriv plant wins EU approval
February 28, 2012Manufacturing and Production EMA, Shire, Vpriv
Shire has been told by the European Medicines Agency that it can make use of a manufacturing facility in Lexington, …
Glivec cleared for longer use in GIST patients
February 28, 2012Sales and Marketing Europe, GIST, Gleevec, Glivec, Novartis
Glivec has gained EU approval for extended use after surgery for adults with KIT (CD117)-positive gastrointestinal stromal tumours (GIST).The drug …
Lilly plans €330m biomanufacturing plant in Ireland
February 28, 2012Manufacturing and Production Abbott, Ireland, Kinsale, lilly
There was more good news for Ireland’s pharmaceutical sector this week with the announcement by Eli Lilly that it will …
Endo says Opana ER supply disruption will be temporary
February 28, 2012Manufacturing and Production Endo, Novartis, Opana ER
Endo Pharmaceuticals has said that current supply restrictions for its new Opana ER formulation of oxymorphone are likely to be …
Priorclave Introduce Autoclave Application Selector at Arab Lab
February 27, 2012Manufacturing and Production
It is not unexpected to find that senior managers from British autoclave manufacturer Priorclave will be making their way East …
Witty hits out at ‘systematic delays’ to medicines
February 27, 2012Sales and Marketing Europe, GSK, NICE, austerity
GlaxoSmithKline’s chief executive says Europe’s drug budget cuts are undermining the industry and not addressing the biggest cost pressure in …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
